Atsufumi Kawabata Selected Research

disodium isostearyl 2-O-L-ascorbyl phosphate

6/2012

Topical application of disodium isostearyl 2-O-L-ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsufumi Kawabata Research Topics

Disease

55	Hyperalgesia 06/2023 - 06/2002
42	Pain (Aches) 01/2024 - 06/2003
17	Visceral Pain 01/2023 - 03/2004
12	Peripheral Nervous System Diseases (PNS Diseases) 01/2024 - 01/2016
12	Neoplasms (Cancer) 01/2023 - 06/2012
12	Cystitis 01/2023 - 06/2011
11	Inflammation (Inflammations) 01/2023 - 12/2003
10	Pancreatitis 01/2023 - 05/2006
9	Hypersensitivity (Allergy) 01/2023 - 07/2006
8	Neuralgia (Stump Neuralgia) 01/2023 - 07/2010
6	Intractable Pain 12/2022 - 01/2011
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2015
5	Nociceptive Pain 01/2019 - 11/2010
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2020 - 06/2011
4	Edema (Dropsy) 01/2018 - 08/2006
3	Hypertension (High Blood Pressure) 01/2021 - 07/2004
2	Wounds and Injuries (Trauma) 01/2023 - 01/2020
2	Multiple Myeloma 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2008
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020 - 05/2020
2	Disseminated Intravascular Coagulation 01/2019 - 11/2013
2	Referred Pain 01/2018 - 01/2012
2	Hyperthermia 01/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

17	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
16	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2019 - 11/2007
15	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2023 - 03/2009
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 06/2011
13	ThrombomodulinIBA 05/2021 - 11/2013
12	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2002
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2012
11	sodium bisulfide (NaHS)IBA 01/2019 - 11/2007
10	CeruletideIBA 01/2023 - 05/2006
9	Protein Isoforms (Isoforms)IBA 12/2022 - 07/2012
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2009
8	GasotransmittersIBA 01/2023 - 11/2007
8	Thrombin FDA Link 01/2021 - 06/2002
7	EnzymesIBA 01/2023 - 11/2007
7	LyasesIBA 01/2023 - 10/2012
7	CystathionineIBA 01/2023 - 10/2012
7	NNC 55-0396IBA 06/2019 - 01/2012
5	sodium sulfideIBA 01/2023 - 02/2014
5	Cysteine (L-Cysteine)FDA Link 01/2023 - 11/2007
5	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2014
4	ZincIBA 06/2023 - 02/2015
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 01/2018
4	Toll-Like Receptor 4IBA 01/2021 - 04/2014
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 11/2013
4	Neutralizing AntibodiesIBA 12/2020 - 11/2013
4	Capsaicin (Zostrix)FDA Link 05/2020 - 06/2003
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019 - 06/2012
4	ProstaglandinsIBA 01/2018 - 01/2011
4	Phenobarbital (Luminal)FDA Link 01/2018 - 03/2004
4	LipopolysaccharidesIBA 01/2018 - 04/2014
4	Analgesics (Analgesic Drugs)IBA 01/2016 - 08/2006
4	MibefradilIBA 10/2012 - 11/2007
3	Calcium Channels (Calcium Channel)IBA 01/2023 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 08/2006
3	Hormones (Hormone)IBA 01/2021 - 01/2019
3	Dihydrotachysterol (AT 10)IBA 01/2021 - 08/2006
3	Bortezomib (Velcade)FDA Link 01/2021 - 01/2019
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 04/2014
3	capsazepineIBA 05/2020 - 06/2002
3	AndrogensIBA 01/2019 - 10/2015
3	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
3	2-furoyl-LIGRLO-amideIBA 01/2018 - 05/2006
3	TrypsinIBA 05/2007 - 09/2003
3	seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamideIBA 07/2006 - 06/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2003 - 09/2002
2	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 06/2023 - 01/2018
2	Chelating AgentsIBA 06/2023 - 01/2018
2	Sulfides (Thioethers)IBA 01/2023 - 10/2009
2	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2021
2	Pimozide (Orap)FDA Link 12/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 01/2019
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	Estrogens (Estrogen)FDA Link 05/2021 - 01/2021
2	Butyrates (Butyrate)IBA 02/2021 - 11/2020
2	Bepridil (Vascor)FDA Link 01/2021 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	Vincristine (Oncovin)FDA LinkGeneric 12/2020 - 01/2016
2	PAR-2 ReceptorIBA 11/2020 - 11/2010
2	Substance PIBA 06/2020 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020 - 01/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2017
2	Calcineurin InhibitorsIBA 05/2020 - 01/2017
2	CalcineurinIBA 05/2020 - 01/2017
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 10/2018
2	AntioxidantsIBA 01/2020 - 02/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
2	AsparagineIBA 01/2019 - 01/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 11/2013
2	ethyl pyruvateIBA 10/2018 - 12/2017
2	Clodronic Acid (Clodronate)IBA 10/2018 - 12/2017
2	prolinedithiocarbamate (PDTC)IBA 10/2018 - 01/2018
2	Alanine (L-Alanine)FDA Link 01/2018 - 01/2018
2	CurcuminIBA 01/2018 - 01/2010

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 03/2022 - 02/2013
6	Therapeutics 01/2022 - 11/2004
2	Ligation 01/2018 - 01/2018
2	Injections 12/2017 - 12/2015